Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Britt Masironi x
  • Refine by access: Content accessible to me x
Clear All Modify Search
Denis Stygar Division for Reproductive Endocrinology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital Solna, Q2:08, S-171 76 Stockholm, Sweden

Search for other papers by Denis Stygar in
Google Scholar
PubMed
Close
,
Britt Masironi Division for Reproductive Endocrinology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital Solna, Q2:08, S-171 76 Stockholm, Sweden

Search for other papers by Britt Masironi in
Google Scholar
PubMed
Close
,
Håkan Eriksson Division for Reproductive Endocrinology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital Solna, Q2:08, S-171 76 Stockholm, Sweden

Search for other papers by Håkan Eriksson in
Google Scholar
PubMed
Close
, and
Lena Sahlin Division for Reproductive Endocrinology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital Solna, Q2:08, S-171 76 Stockholm, Sweden

Search for other papers by Lena Sahlin in
Google Scholar
PubMed
Close

Major reproductive events such as menstruation, ovulation, implantation, and cervical ripening are characterized by an increased number of invading leukocytes in the tissues. Sex steroid hormones, particularly estrogens, play an important role in these dynamic changes in the female reproductive tract. Estrogens have also been implicated in the pathogenesis of many common pathological conditions associated with leukocyte infiltration and immunological dysfunction, such as auto-immune diseases and atherosclerosis. Although the two estrogen receptor (ER) subtypes, ERα and ERβ, have been found in different leukocyte populations in tissues and in peripheral blood, there is still very little known about functional activity and importance of ERs in blood cells. To elucidate the different roles for ERα and ERβ in peripheral blood leukocytes, we used microarray gene expression profiling of rat peripheral blood leukocytes subjected to in vivo treatment with estradiol (E2), the selective ERα agonist 4,4′,4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT), and the selective ERβ agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN). We report the identification of genes that were commonly regulated by E2, PPT, and DPN, and genes that were regulated either by the ERα or ERβ agonist. Further confirmatory analyses of the selected regulated genes 12-lipoxygenase, fibulin-1, furin, and calgranulin B are also presented. These results were then compared with those from the uterine tissue of the same animals. Our study demonstrates that peripheral blood leukocytes are responsive to estrogens. E2 and selective ERα and ERβ agonists regulate a number of genes that may contribute to inflammation and remodeling of the extracellular matrix.

Free access